secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ardent Health, Inc. (ARDT)
CIK:        0001756655
Form:       8-K
Filed at:   2024-08-14T23:59:59+00:00
Accession:  0001628280-24-037235
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ardent Health Q2 revenue $1.47B, adj. EBITDA $122M (+20%); issues FY24 guidance
-------------------------------------------------------------------------------

- Q2 revenue $1.47B (+7.5% YoY); net income attributable $43M ($0.34/share).
- Adjusted EBITDA $122M, up 20% YoY; adjusted admissions +3.4%.
- Full-year 2024 guidance: revenue $5.75-5.90B, Adj. EBITDA $415-435M.
- Cash from ops $120M (+$77M YoY); prepaid $100M term loan; net leverage 2.3x.
- IPO net proceeds $209M (13.8M shares at $16); pro forma liquidity ~$832M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756655/000162828024037235/0001628280-24-037235-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756655/000162828024037235/ardt-20240814.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-037235

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer